Antibody profile in post-vaccinated & SARS-CoV-2 infected individuals

BACKGROUND & OBJECTIVES: During the COVID-19 pandemic it was important to assess the antibody profile in individuals vaccinated with Covaxin (BBV152) and Covishield (ChAdOx1 nCoV-19) with both 28 and 84 days gaps between two doses, those infected with SARS-CoV-2 and post-COVID-19-infected indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Rucha, Shanbhag, Sharda, Shankarkumar, Aruna, Madkaikar, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807196/
https://www.ncbi.nlm.nih.gov/pubmed/36124500
http://dx.doi.org/10.4103/ijmr.ijmr_3330_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807196/
https://www.ncbi.nlm.nih.gov/pubmed/36124500
http://dx.doi.org/10.4103/ijmr.ijmr_3330_21

Ejemplares similares